News
-
Intranasal drug developer Impel NeuroPharma has hired Lynn C. Gold as Senior VP of Regulatory Affairs, the company said. Gold was most recently VP of Scientific and Regulatory Affairs at Camargo Pharmaceutical Services and had… Read more . . .
-
According to reports, Montenegrin pharmaceutical company Hemomont has officially opened a €5.3 million, 1,700 square meter nasal spray manufacturing facility in Podgorica that is expected to employ 30 people and produce 3 million units per… Read more . . .
-
In a business update, Gerresheimer announced that it has gained one large order for inhaler manufacturing in Europe but has lost another because “the customer’s inhaler business fell short of its expectations.” As a result,… Read more . . .
-
Oyster Point Pharma has announced that the Phase 2b PEARL study of its OC-02 intranasal nicotinic acetylcholine receptor (nAChR) agonist for the treatment of dry eye disease demonstrated a statistically significant increase in production of… Read more . . .
-
Inhalation Sciences subsidiary Ziccum has been awarded a grant of 500,000 SEK (~ €48,600) by the EU’s Horizon 2020 research and innovation project for scale up of its LaminarPace spray drying technology, the company said.… Read more . . .
-
TFF Pharmaceuticals said that it has received a notice of allowance for US Patent Application No. 12/778,795, titled, “Compositions and Methods of Making Brittle-Matrix Particles Through Blister Pack Freezing,” which covers technology related to the… Read more . . .
-
Glenmark Pharmaceuticals has announced that it will receive an unspecified amount up front, plus regulatory and commercial milestone payments, from Seqirus for the rights to commercialize Ryaltris olopatadine hydrochloride/mometasone furoate nasal spray in Australia and… Read more . . .
-
Senzer Ltd has announced plans to launch several inhaled cannabinoid products in the UK, beginning with its Cannafen cannabidiol inhalation solution later this year. Senzer is a subsidiary of Kind Consumer, whose Voke nicotine inhaler… Read more . . .
-
Amiko Digital Health has announced that Portuguese health care group Luz Saúde has signed an agreement for the use of Amiko’s Respiro inhaler monitoring platform for asthma and COPD management. Earlier this year, Amiko announced… Read more . . .
-
Catalent has announced that it will acquire Juniper Pharma Services (formerly Molecular Profiles) along with its parent company Juniper Pharmaceuticals. Catalent will pay $11.50 per share to acquire all of Juniper Pharmaceuticals’ stock. Juniper Pharmaceuticals… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA